Reuter A, Tisile P, von Delft D, Cox HS, Cox V, et al.
2017-11-01 • International Journal of Tuberculosis and Lung Disease
2017-11-01 • International Journal of Tuberculosis and Lung Disease
For decades, second-line injectable agents (IAs) have been the cornerstone of treatment for multidrug-resistant tuberculosis (MDR-TB). Although evidence on the efficacy of IAs is limited...
2017-05-01 • Bulletin of the World Health Organization
Saran K, Masini T, Chikwanha I, Paton G, Scourse R, et al.
2019-02-01 • bioRxiv
2019-02-01 • bioRxiv
BACKGROUND Tuberculosis (TB) poses a global health crisis requiring robust international and country-level action. Adopting and implementing TB policies from the World Health Organiz...
